The U.S. Supreme Court is scheduled to hear arguments February 28 on a Stanford University case against pharmaceutical company Roche Holding AG over HIV-related patent rights of its researchers, Drug Discovery and Development reports. Stanford is suing Roche over the patents to testing methods for evaluating AIDS treatments, which Stanford insists were developed by a university researcher. Stanford holds title to the patents under the University and Small Business Patent Procedures Act, or Bayh-Dole Act, which evenly divides all royalties from inventions born out of federally funded research between the inventors, their academic departments and their schools.

To read the Drug Discovery and Development article, click here.